title: NTR Is the New SSTR? Perspective for Neurotensin Receptor 1 (NTR)-Directed Theranostics.
authors.affiliation: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; and wfendler@mednet.ucla.edu.
authors.forename: Wolfgang P
authors.initials: WP
authors.lastname: Fendler
authors.affiliation: Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik, Bad Berka, Germany.
authors.forename: Richard P
authors.initials: RP
authors.lastname: Baum
mesh_terms: D000818:Animals; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000532:radiotherapy*; D019275:Radiopharmaceuticals; D018028:Receptors, Neurotensin / Q000032:analysis*; D017481:Receptors, Somatostatin / Q000032:analysis*; D000068936:Theranostic Nanomedicine; D016896:Treatment Outcome
chemical_list: D019275:Radiopharmaceuticals; D018028:Receptors, Neurotensin; D017481:Receptors, Somatostatin; C114036:neurotensin type 1 receptor